ER

Expert Review of Vaccines

Expert Review of Vaccines is a MEDLINE-indexed, international peer-reviewed journal publishing research on the development, application, and clinical effectiveness of new vaccines. It covers reviews and original articles on vaccines, immune response, immunization, vaccine technologies and platforms, adjuvants, therapeutic vaccines, and vaccination for non-communicable diseases, and uses double-anonymous peer review after editorial suitability assessment. The journal converted to full Open Access from Volume 22 (2023), while previous volumes remain pay to read.

Looking to publish in Expert Review of Vaccines? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology
Impact Factor 4.8
Quartile Q2
Open Access Type Open
ISSN 1476-0584
eISSN 1744-8395
Invitation Only No
Cost Range Article Publishing Charge (APC) may apply; authors may be able to publish at no cost to themselves or with a reduced APC through open access agreements, memberships, discounts, or waivers.

Submission Instructions

Expert Review of Vaccines accepts the following article types. Click on an article type to view submission instructions.

Original Research

Cover Letter A covering letter is required for Original Research submissions. The covering letter must give the corresponding author's full contact details and include statements on originality, all authors' approval and ICMJE compliance, the body granting ethical approval, and any declarable financial or other support relationships.
Abstract A brief structured abstract is required on the second page. The abstract must not exceed 200 words. The abstract must be structured. The abstract must use the headings Background, Research design and methods, Results, and Conclusions, and clinical trial abstracts must also include Trial Registration.
Manuscript The article body must include the sections introduction, patients and methods, results, discussion, and conclusions. The manuscript must include 4–6 keywords in alphabetical order, an author contributions section, an acknowledgements section, and a disclosure form.
References References must use NLM style. References must be full and current, use primary sources where possible, and keep unpublished data or personal communications to a minimum with permission obtained for cited unpublished results or personal communications.
Figures & Tables A maximum of five figures and five tables is permitted. Tables must be editable and figures should be used to present results clearly.
Reformat to Expert Review of Vaccines using Livewrite Premium

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must not exceed 200 words. Abstract must not exceed 200 words. Abstract must be structured. Abstract must use the headings Introduction, Areas covered, and Expert opinion.
Manuscript Body of the review must not exceed 7000 words. Manuscript must include Introduction, Body with numbered subsections, Conclusion placed before an additional Expert Opinion section, and the Expert Opinion section must be at least 500 words. Manuscript must include an Article Highlights section, 4–10 keywords in alphabetical order, and an annotated bibliography with important references marked by a one/two-star system and brief annotations.
References Review articles should include around 100 references. References must use NLM style. All key relevant work must be cited in the text and listed in the bibliography, unpublished data should be kept to a minimum, and important references must be marked with one or two stars and brief annotations.
Figures & Tables Review articles may include up to 5 figures and up to 5 tables.
Reformat to Expert Review of Vaccines using Livewrite Premium

Vaccine Profile

Cover Letter Cover Letter requirements are not specified.
Abstract Vaccine Profiles must include an abstract. Abstract must not exceed 200 words. Abstract must be structured. Abstract must use the headings Introduction, Areas covered, and Expert opinion.
Manuscript Manuscript must be 3,000-7,000 words excluding tables, figures, and references. Manuscript must include Introduction, Overview of market, Introduction to the vaccine, Clinical efficacy, Regulatory affairs, Conclusion, Expert Opinion, and Information resources sections, with Post-marketing surveillance included if applicable. Manuscript must include a brief alphabetical keyword list, article highlights as bulleted main points, and an annotated bibliography with important references marked by * or ** and briefly explained.
References References must use NLM style. References of interest must be identified with * or ** and accompanied by a brief sentence explaining why they are of interest.
Figures & Tables A maximum of five figures and five tables is permitted. Clinical efficacy must include summary tables of Phase I/II and Phase III trial results, and Post-marketing surveillance must include a table summarizing safety outcomes in clinical trials and a table comparing the vaccine with its competitors.
Reformat to Expert Review of Vaccines using Livewrite Premium

Clinical Trial Report

Cover Letter Cover Letter requirements are not specified.
Abstract A summary is required and must not exceed 150 words. Summary must be no more than 150 words. Summary must not be an abstract and should be unstructured.
Manuscript Manuscript must be 3,000–7,000 words excluding tables, figures, and references. Manuscript must include a concise informative title with the drug and therapeutic indication, an introduction covering disease incidence and prevalence, unmet medical need and treatment guidelines with regional variations where appropriate, a section entitled Expert Opinion, and a Five-year view. Manuscript must include a brief list of keywords in alphabetical order and article highlights presented as a bulleted executive summary of the authors’ main points.
References References must use NLM style. References of particular interest must be marked with one or two asterisks and accompanied by a brief sentence explaining why they are of interest.
Figures & Tables A maximum of five figures and five tables is permitted. Tables must present new information, be interpretable without reference to the text, and be supplied as editable files.
Reformat to Expert Review of Vaccines using Livewrite Premium

Systematic Review

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 200 words. Abstract must be structured. Abstract must use the headings Introduction, Methods, Results, and Conclusions.
Manuscript Manuscript body must include the sections Introduction, Methods, Results, and Discussion. Manuscript must include 4 to 10 keywords in alphabetical order and registration details including registration numbers where applicable.
References References must use NLM style. Each study included in the analysis must be cited, and references of particular interest must be marked with one or two asterisks and briefly explained.
Figures & Tables Up to 5 figures and up to 5 tables are permitted. Tables or plots must be used to support presentation of outcome statistics, effect estimates, and precision.
Reformat to Expert Review of Vaccines using Livewrite Premium

Meta-Analysis

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 200 words. Abstract must be structured with the headings Introduction, Methods, Results, and Conclusions. Abstract must include the headings Introduction, Methods, Results, and Conclusions, with content specifying the objective or question, study design, information sources, inclusion and exclusion criteria, bias assessment, methods, study and participant counts, main outcomes, meta-analytic summary estimates and intervals where applicable, direction of effect for group comparisons, interpretation, implications, and limitations.
Manuscript Body of the article must include the sections Introduction, Methods, Results, and Discussion. Manuscript must include 4 to 10 keywords in alphabetical order and registration details including registration numbers where applicable.
References References must use NLM style. Each study included in the analysis must be cited, and references of particular interest must be marked with one or two asterisks plus a brief explanatory sentence.
Figures & Tables Up to 5 figures and up to 5 tables are permitted. Tables or plots must be used to support presentation of outcome statistics, effect estimates, and precision.
Reformat to Expert Review of Vaccines using Livewrite Premium

Special Report

Cover Letter Cover Letter requirements are not specified.
Abstract Special Reports must include an abstract. The abstract must not exceed 200 words. The abstract must be structured. The abstract must use the headings Introduction, Areas covered, and Expert Opinion.
Manuscript Special Reports must be 1,500-3,000 words excluding figures, tables, and references. Special Reports must include an Introduction, a body with numbered subsections, a distinct Conclusion appearing before the Expert Opinion section, and an Expert Opinion section. Special Reports must include a brief list of keywords in alphabetical order and article highlights as a bulleted list of five or six points covering the key aspects of the paper.
References Special Reports should include no more than 100 references. References must use NLM style. References of particular interest must be marked with one or two asterisks and accompanied by a brief sentence explaining why the reference is of interest.
Figures & Tables Special Reports may include up to 5 figures and up to 5 tables. Permission documentation for any previously published figures must be uploaded alongside the manuscript.
Reformat to Expert Review of Vaccines using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must be no more than 1500 words excluding references. Letters to the Editor should discuss an article previously published in the journal. Letters to the Editor must include the author's name, address, and contact details.
References Letters to the Editor may include a maximum of 15 references, including the article under discussion. References must use NLM style. References of particular interest must be marked with one or two asterisks and accompanied by a brief sentence explaining why they are of interest.
Figures & Tables Letters to the Editor must not include figures or tables.
Reformat to Expert Review of Vaccines using Livewrite Premium

Key Paper Evaluation

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must not exceed 200 words. Abstract must not exceed 200 words. Abstract structure type is not specified for this article type. Abstract must outline the article scope and briefly put it into context.
Manuscript Manuscript must be 1,000-1,500 words excluding abstract, keywords, and references. Manuscript must include Introduction, Summary of methods and results, Discussion, and Conclusion, and the Introduction must cite the paper under discussion as Reference [1]. Manuscript must include a brief list of keywords in alphabetical order and a financial disclosure and acknowledgements section declaring interests, relevant affiliations or entities, and contributions or assistance.
References References are limited to a maximum of 15. References must use NLM style. References of particular interest must be marked with one or two asterisks and accompanied by a brief sentence explaining their significance.
Figures & Tables No more than one figure and one table may be included.
Reformat to Expert Review of Vaccines using Livewrite Premium

Recent Publications

Narrative review of the clinical safety of MenACYW-TT: a quadrivalent meningococcal vaccine conjugated to tetanus toxoid licensed in the US and abroad

Olga Syrkina, Mary Bausch-Jurken, Arlette Delgado, Jelena Jovanovic, Corwin A. Robertson

10.1080/14760584.2026.2724614
View Publication

Stroke risk following BNT162b2 vaccination: a systematic review and meta-analysis of self-controlled case series studies

Seol Jang, Sung-Inn Pyo, Eun Jin Kim, Woojoo Lee, Soon-Sun Kwon

10.1080/14760584.2026.2720955
View Publication

Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe, 2015/16–2024/25

Diogo F. P. Marques, Angela M. C. Rose, Susana Monge, Iván Martínez-Baz, Marijke Reynders, Róisín Duffy, Sierk D. Marbus, Silvia Bino, Petr Husa, Ralf Dürrwald, Liem Binh Luong Nguyen, Goranka Petrović, Beatrix Oroszi, Antonino Bella, Monika Kuliese, Stephen Abela, Iwona Paradowska-Stankiewicz, Ausenda Machado, Odette Popovici, Chris Robertson, Francisco Pozo, Ana S. Lameiras Azevedo, Camino Trobajo-Sanmartín, Anna Parys, Lisa Domegan, Arianne B. van Gageldonk-Lafeber, Lenka Součková, Kristin Tolksdorf, Odile Launay, Vesna Višekruna Vučina, Gergő Túri, Flavia Riccardo, Ligita Jančorienė, John Paul Cauchi, Verónica Gómez, Mihaela Lazar, Jim McMenamin, Baltazar Nunes

10.1080/14760584.2026.2722420
View Publication

Cohort studies may underestimate rare vaccine adverse events: evidence from stroke incidence following COVID-19 vaccination

Hiam Chemaitelly, Naveed Akhtar, Salman Al Jerdi, Saadat Kamran, Sujatha Joseph, Deborah Morgan, Ryan Uy, Fatma B. Abid, Abdullatif Al-Khal, Abdul-Badi Abou-Samra, Adeel A. Butt, Laith J. Abu-Raddad

10.1080/14760584.2026.2720953
View Publication

Comparison of immunogenicity, safety, and efficacy of EVA71 vaccine in children: a systematic review and meta-analysis

Muhammad Gilang Dwi Putra, Rodman Tarigan Girsang, Rais Amaral Haq, Teuku Fais Duta, Frengki Prabowo Saputro Wijayanto, Artha Maressa Theodora Simanjuntak, Eddy Fadlyana, Kusnandi Rusmil

10.1080/14760584.2026.2722426
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A covering letter is required. It must include corresponding author contact details, statements of originality and exclusive submission, author approval, ethical approval, and disclosure of financial or other relationships. Manuscripts without a covering letter or a disclosure form are not considered complete submissions.

Reformat to Expert Review of Vaccines using Livewrite Premium

What are the publication costs?

Full Open Access from Volume 22 (2023); previous volumes are pay to read.

Reformat to Expert Review of Vaccines using Livewrite Premium

Research Topics

Immunotherapy and Immune Responses Influenza Virus Research Studies Vaccine Coverage and Hesitancy Respiratory viral infections research Pneumonia and Respiratory Infections vaccines and immunoinformatics approaches SARS-CoV-2 and COVID-19 Research Viral gastroenteritis research and epidemiology Bacterial Infections and Vaccines Hepatitis B Virus Studies Immune responses and vaccinations Mosquito-borne diseases and control Virology and Viral Diseases Viral Infections and Outbreaks Research Herpesvirus Infections and Treatments HIV Research and Treatment Viral Infections and Immunology Research RNA Interference and Gene Delivery Immune Response and Inflammation Hepatitis Viruses Studies and Epidemiology Cervical Cancer and HPV Research Viral Infections and Vectors Virus-based gene therapy research Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research

Related Journals

JO
Journal of Virus Eradication Elsevier BV
Ai
AIDS LIPPINCOTT WILLIAMS & WILKINS
Bi
BioDrugs Adis, Springer Healthcare
TA
Transplantation and Cellular Therapy Elsevier BV
AO
Annals of Allergy Asthma & Immunology Elsevier BV
BB
Brain Behavior & Immunity - Health Elsevier BV